Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06189183
NA

Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate the efficiency and toxicity of adjuvant hypofractionation radiotherapy for thymic epithelial tumours after complete resection.

Official title: Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection-Single Center Phase II Single Arm Clinical Trial

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2023-11-11

Completion Date

2040-12-31

Last Updated

2026-04-01

Healthy Volunteers

No

Interventions

RADIATION

Adjuvant Hypofractionation Radiotherapy

Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection

Locations (1)

National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College

Beijing, Beijing Municipality, China